|
US5205290A
(en)
|
1991-04-05 |
1993-04-27 |
Unger Evan C |
Low density microspheres and their use as contrast agents for computed tomography
|
|
US6334997B1
(en)
*
|
1994-03-25 |
2002-01-01 |
Isotechnika, Inc. |
Method of using deuterated calcium channel blockers
|
|
CN1217007C
(zh)
*
|
1997-02-14 |
2005-08-31 |
乔治华盛顿大学 |
测量dna合成率的分析方法
|
|
US6312450B1
(en)
|
1997-05-20 |
2001-11-06 |
Natural Vision Center, Inc. |
System and method for improving the appearance of skin
|
|
US6884429B2
(en)
|
1997-09-05 |
2005-04-26 |
Isotechnika International Inc. |
Medical devices incorporating deuterated rapamycin for controlled delivery thereof
|
|
EP1645565B1
(en)
*
|
1997-10-08 |
2009-02-18 |
Isotechnika Inc. |
Deuterated cyclosporine analogs and their use as immunomodulating agents
|
|
ES2256959T3
(es)
|
1997-10-08 |
2006-07-16 |
Isotechnika,Inc. |
Analogos de ciclosporina deuterados y no deuterados y su uso como agentes inmunomoduladores.
|
|
US20030220234A1
(en)
*
|
1998-11-02 |
2003-11-27 |
Selvaraj Naicker |
Deuterated cyclosporine analogs and their use as immunodulating agents
|
|
US6333342B1
(en)
*
|
1998-11-04 |
2001-12-25 |
Isotechnika, Inc |
Methods of pharmacological treatment using S(−) amlodipine
|
|
US6376531B1
(en)
|
1998-11-13 |
2002-04-23 |
Rupert Charles Bell |
Method of treatment using deuterium compounds
|
|
US7323341B1
(en)
|
1999-07-09 |
2008-01-29 |
Jasper John P |
Stable isotopic identification and method for identifying products by isotopic concentration
|
|
US6254594B1
(en)
|
1999-07-30 |
2001-07-03 |
Quadrivium, Llc |
Disposable light source for photothermal treatment of human tissue
|
|
RU2181297C2
(ru)
|
2000-06-20 |
2002-04-20 |
Эпштейн Олег Ильич |
Способ лечения патологического синдрома и лекарственное средство
|
|
US6579630B2
(en)
|
2000-12-07 |
2003-06-17 |
Canon Kabushiki Kaisha |
Deuterated semiconducting organic compounds used for opto-electronic devices
|
|
US6872408B2
(en)
*
|
2001-09-07 |
2005-03-29 |
Rupert C. Bell |
Method of treating bipolar disorders using deuterium-substituted carbonate
|
|
ES2334650T3
(es)
*
|
2001-10-16 |
2010-03-15 |
Memory Pharmaceuticals Corporation |
Derivados de 4(4-alkoxi-3-hidroxifenil)-2-pirrolidona como inhibidores de pde-4 para el tratamiento de sindromes neurologicos.
|
|
AU2002331509B2
(en)
|
2001-10-19 |
2007-12-06 |
Aurinia Pharmaceuticals Inc. |
Synthesis of cyclosporin analogs
|
|
RU2201255C1
(ru)
*
|
2001-12-26 |
2003-03-27 |
Эпштейн Олег Ильич |
Лекарственное средство и способ регуляции сосудистого тонуса
|
|
DE10205432A1
(de)
*
|
2002-02-07 |
2003-08-21 |
Bdd Group Holding Ag Zug |
Deuterierte biphenylsubstituierte Spirocyclopentanimidazoline sowie diese Verbindungen enthaltende Arzneimittel
|
|
UA76639C2
(uk)
*
|
2002-08-02 |
2006-08-15 |
Олєг Ільіч Епштєйн |
Гомеопатичний лікарський засіб та спосіб лікування еректильних дисфункцій
|
|
UA76640C2
(uk)
*
|
2002-08-02 |
2006-08-15 |
Олєг Ільіч Епштєйн |
Спосіб корекції патологічних імунних реакцій та гомеопатичний лікарський засіб
|
|
AU2003265842A1
(en)
|
2002-08-30 |
2004-03-19 |
Memory Pharmaceuticals Corporation |
Anabaseine derivatives useful in the treatment of neurodegenerative diseases
|
|
EP2305675A1
(en)
|
2002-09-25 |
2011-04-06 |
Memory Pharmaceuticals Corporation |
Indazoles, Benzothiazoles, and Benzoisothiazoles, and preparation and uses thereof
|
|
NZ540138A
(en)
|
2002-11-19 |
2008-07-31 |
Memory Pharm Corp |
Pyridine n-oxide compounds as phosphodiesterase 4 inhibitors
|
|
AU2004222306A1
(en)
*
|
2003-03-17 |
2004-09-30 |
Albany Molecular Research, Inc. |
Novel cyclosporins
|
|
WO2004094375A2
(en)
*
|
2003-04-16 |
2004-11-04 |
Memory Pharmaceuticals Corporation |
4 - (3,4 - disubstituted phenyl) - pyrrolidin-2-one compounds as phosphodiesterase 4 inhibitors
|
|
MXPA05011200A
(es)
*
|
2003-04-18 |
2005-12-14 |
Memory Pharm Corp |
Derivados de pirazol como inhibidores de fosfodiesterasa 4.
|
|
WO2005020840A2
(en)
*
|
2003-08-21 |
2005-03-10 |
Thomas Tobin |
Composition and method for marking procaine penicillin
|
|
RU2253478C1
(ru)
*
|
2003-10-01 |
2005-06-10 |
Эпштейн Олег Ильич |
Средство для потенцирования лечебных эффектов - усиления действия лекарственного вещества
|
|
US20050153953A1
(en)
*
|
2003-11-21 |
2005-07-14 |
Crista Trippodi-Murphy |
Compositions and methods of treatment using L-type calcium channel blockers and cholinesterase inhibitors
|
|
BRPI0508771A
(pt)
|
2004-03-25 |
2007-08-14 |
Memory Pharm Corp |
indazóis, benzotiazóis, benzoisotiazóis, benzisoxazóis, e a preparação e usos dos mesmos
|
|
US7705036B2
(en)
*
|
2004-04-01 |
2010-04-27 |
Cardiome Pharma Corp. |
Deuterated aminocyclohexyl ether compounds and processes for preparing same
|
|
CA2561733A1
(en)
*
|
2004-04-01 |
2005-10-13 |
Cardiome Pharma Corp. |
Pegylated ion channel modulating compounds
|
|
JP2008514701A
(ja)
*
|
2004-09-29 |
2008-05-08 |
エーエムアール テクノロジー インコーポレイテッド |
シクロスポリンアルキン類似体およびそれらの薬学的使用
|
|
EP1804823A4
(en)
*
|
2004-09-29 |
2010-06-09 |
Amr Technology Inc |
NEW CYCLOSPORIN ANALOGUE AND ITS PHARMACEUTICAL APPLICATIONS
|
|
JP2008515886A
(ja)
*
|
2004-10-06 |
2008-05-15 |
エーエムアール テクノロジー インコーポレイテッド |
シクロスポリンアルキンおよびそれらの医用薬剤としての有用性
|
|
CA2584317A1
(en)
*
|
2004-10-15 |
2006-04-27 |
Memory Pharmaceuticals Corporation |
Pyrazole derivatives as phosphodiesterase 4 inhibitors
|
|
US7585882B2
(en)
*
|
2004-10-20 |
2009-09-08 |
Memory Pharmaceuticals Corporation |
Phosphodiesterase 4 inhibitors
|
|
WO2006088525A1
(en)
|
2004-11-18 |
2006-08-24 |
Cardiome Pharma Corp. |
Synthetic process for aminocyclohexyl ether compounds
|
|
CA2612375C
(en)
|
2005-06-15 |
2013-08-06 |
Cardiome Pharma Corp. |
Synthetic processes for the preparation of aminocyclohexyl ether compounds
|
|
AU2006274037B2
(en)
*
|
2005-07-26 |
2012-04-26 |
Takeda Gmbh |
Isotopically substituted pantoprazole
|
|
WO2007012650A1
(en)
*
|
2005-07-26 |
2007-02-01 |
Nycomed Gmbh |
Isotopically substituted proton pump inhibitors
|
|
BRPI0615973A2
(pt)
|
2005-07-29 |
2011-05-31 |
Concert Pharmaceuticals Inc |
novos derivados de benzo [d] [1,3] - dioxol
|
|
US7863274B2
(en)
|
2005-07-29 |
2011-01-04 |
Concert Pharmaceuticals Inc. |
Deuterium enriched analogues of tadalafil as PDE5 inhibitors
|
|
BRPI0617987A2
(pt)
|
2005-10-06 |
2011-08-16 |
Auspex Pharmaceuticals Inc |
composição, composição farmacêutica, forma de dosagem efervescente, composição farmacêutica oral de comprimidos unitários múltiplos, forma de dosagem farmacêutica de liberação prolongada, forma de dosagem farmacêutica revestida entérica, forma de dosagem farmacêutica estável para administração oral a sujeitos mamìferos, método para tratamento de doenças relacionadas a ácido gástrico pela inibição de secreção de ácido gástrico, método para tratamento de uma infecção bacteriana provocada ou mediada por helicobacter pylori, processo para preparar um composto da fórmula 3, processo para preparar um composto da fórmula 5, uso de um composto da fórmula 1 para a preparação de um medicamento para tratamento de doenças relacionadas a ácido gástrico, pela inibição de secreção de ácido gástrico, uso de um composto da fórmula 1 para a preparação de um medicamento para tratamento de uma infecção bacteriana provocada ou mediada por helicobacter pylori uso de um composto da fórmula 1 para a preparação de um medicamento para tratamento de doenças relecionadas a ácido gástrico pela inibição de secreção de ácido gástrico
|
|
HUE027865T2
(en)
|
2005-12-01 |
2016-11-28 |
Auspex Pharmaceuticals Inc |
Substituted phenyl ethylamines with serotonergic and / or norepinephrine activity
|
|
RU2309732C1
(ru)
*
|
2006-03-13 |
2007-11-10 |
Олег Ильич Эпштейн |
Спрессованная твердая оральная форма лекарственного препарата и способ получения твердой оральной формы лекарственного препарата
|
|
US7696165B2
(en)
*
|
2006-03-28 |
2010-04-13 |
Albany Molecular Research, Inc. |
Use of cyclosporin alkyne analogues for preventing or treating viral-induced disorders
|
|
US7696166B2
(en)
*
|
2006-03-28 |
2010-04-13 |
Albany Molecular Research, Inc. |
Use of cyclosporin alkyne/alkene analogues for preventing or treating viral-induced disorders
|
|
CA2653262A1
(en)
*
|
2006-05-26 |
2007-12-06 |
Auspex Pharmaceuticals, Inc. |
Preparation and utility of substituted carboxylic acid compounds
|
|
US8367414B2
(en)
|
2006-05-30 |
2013-02-05 |
Jasper John P |
Tracing processes between precursors and products by utilizing isotopic relationships
|
|
CN101516879A
(zh)
|
2006-06-05 |
2009-08-26 |
奥斯拜客斯制药有限公司 |
具有催眠作用的取代的咪唑并吡啶化合物的制备及用途
|
|
US20070281894A1
(en)
*
|
2006-06-05 |
2007-12-06 |
Auspex Pharmaceuticals, Inc. |
Preparation and utility of substituted erythromycin analogs
|
|
US8299248B2
(en)
|
2006-08-02 |
2012-10-30 |
Cytokinetics, Incorporated |
Certain 1H-imidazo[4,5-b]pyrazin-2(3H)-ones and 1H-imidazo[4,5-b]pyrazin-2-ols and methods for their use
|
|
CN101547696A
(zh)
*
|
2006-08-08 |
2009-09-30 |
奥斯拜客斯制药有限公司 |
具有α肾上腺素能阻断效应的取代喹唑啉化合物的制备和应用
|
|
JP2010501011A
(ja)
|
2006-08-16 |
2010-01-14 |
オースペックス・ファーマシューティカルズ・インコーポレイテッド |
オピオイド鎮痛薬の調製および効用
|
|
US8796267B2
(en)
|
2006-10-23 |
2014-08-05 |
Concert Pharmaceuticals, Inc. |
Oxazolidinone derivatives and methods of use
|
|
CA2669687C
(en)
*
|
2006-11-15 |
2013-09-10 |
Forest Laboratories Holdings Limited |
Phthalazine derivatives
|
|
US7932235B2
(en)
|
2006-11-17 |
2011-04-26 |
Concert Pharmaceuticals, Inc. |
Triazolyl tropane derivatives
|
|
WO2008070619A1
(en)
*
|
2006-12-04 |
2008-06-12 |
Auspex Pharmaceuticals, Inc. |
Deuterated oxazolidinones and their use as antibiotics
|
|
WO2008076949A2
(en)
|
2006-12-15 |
2008-06-26 |
Concert Pharmaceuticals Inc. |
Quinazoline derivatives and methods of treatment
|
|
WO2008088727A2
(en)
*
|
2007-01-12 |
2008-07-24 |
Concert Pharmaceuticals, Inc. |
Endothelin receptor antagonists
|
|
US8080549B2
(en)
|
2007-01-12 |
2011-12-20 |
Concert Pharmaceuticals, Inc. |
Endothelin receptor antagonists
|
|
WO2008106125A2
(en)
|
2007-02-26 |
2008-09-04 |
Concert Pharmaceuticals, Inc. |
Deuterated derivatives of silodosin as alpha la-adrenoceptor antagonists
|
|
JP2010520291A
(ja)
|
2007-03-07 |
2010-06-10 |
コンサート ファーマシューティカルズ インコーポレイテッド |
抗狭心症化合物としての重水素化ピペラジン誘導体
|
|
TW200846305A
(en)
|
2007-03-15 |
2008-12-01 |
Auspex Pharmaceuticals Inc |
Substituted phenethylamines with serotoninergic and/or norepinephrinergic activity
|
|
EP2918578A1
(en)
|
2007-03-16 |
2015-09-16 |
Concert Pharmaceuticals, Inc. |
Inhibitors of cholesterol ester transfer protein
|
|
BRPI0809740A2
(pt)
|
2007-04-10 |
2014-11-04 |
Auspex Pharmaceuticals Inc |
"composto, composição farmacêutica, método para tratamento, prevenção ou melhora de um ou mais sintomas de uma desordem mediada pela endotelina, método de inibição da ligação de uma endotelina para um receptor et ou et e, método para modular atividade mediada pelo recptor de endotelina"
|
|
WO2008133949A1
(en)
|
2007-04-25 |
2008-11-06 |
Concert Pharmaceuticals, Inc. |
Analogues of cilostazol
|
|
US8349817B2
(en)
|
2007-04-25 |
2013-01-08 |
Concert Pharmaceuticals, Inc. |
Analogues of cilostazol
|
|
WO2008134525A1
(en)
|
2007-04-26 |
2008-11-06 |
Auspex Pharmaeuticals, Inc. |
Deuterium labelled ketamine
|
|
PL2522668T3
(pl)
|
2007-05-01 |
2015-07-31 |
Concert Pharmaceuticals Inc |
Związki morfinanu
|
|
FI3825306T3
(fi)
|
2007-05-01 |
2023-08-23 |
Concert Pharmaceuticals Inc |
Morfinaaniyhdisteitä
|
|
US7820666B2
(en)
|
2007-05-08 |
2010-10-26 |
Concert Pharmaceuticals, Inc. |
Tetrahydrotriazolopyrazine derivatives and uses thereof
|
|
US20080280970A1
(en)
|
2007-05-08 |
2008-11-13 |
Czarnik Anthony W |
Deuterium-enriched atorvastatin
|
|
HUP0700353A2
(en)
*
|
2007-05-18 |
2008-12-29 |
Richter Gedeon Nyrt |
Metabolites of (thio)carbamoyl-cyclohexane derivatives
|
|
US7531685B2
(en)
*
|
2007-06-01 |
2009-05-12 |
Protia, Llc |
Deuterium-enriched oxybutynin
|
|
US7745665B2
(en)
|
2007-06-04 |
2010-06-29 |
Auspex Pharmaceuticals, Inc. |
Substituted phenethylamines
|
|
ES2395137T3
(es)
|
2007-06-12 |
2013-02-08 |
Concert Pharmaceuticals, Inc. |
Derivados de azapéptidos como inhibidores de la proteasa VIH
|
|
US20080312318A1
(en)
*
|
2007-06-14 |
2008-12-18 |
Protia, Llc |
Deuterium-enriched escitalopram
|
|
US20080318964A1
(en)
*
|
2007-06-19 |
2008-12-25 |
Protia, Llc |
Deuterium-enriched eszopiclone
|
|
KR101767849B1
(ko)
|
2007-06-20 |
2017-08-11 |
오스펙스 파마슈티칼스, 인코포레이티드 |
섬유증 저해제로서의 치환된 ｎ-아릴 피리디논
|
|
US7915309B2
(en)
|
2007-06-20 |
2011-03-29 |
Protia, Llc |
Deuterium-enriched oseltamivir
|
|
US7687509B2
(en)
|
2007-07-09 |
2010-03-30 |
Concert Pharmaceuticals Inc. |
Pyrimidinecarboxamide derivatives
|
|
CN101835749A
(zh)
*
|
2007-07-30 |
2010-09-15 |
奥斯拜客斯制药有限公司 |
取代的吲哚
|
|
JP5389028B2
(ja)
|
2007-08-14 |
2014-01-15 |
コンサート ファーマシューティカルズ インコーポレイテッド |
置換オキサゾリジノン誘導体
|
|
US20090062182A1
(en)
*
|
2007-08-29 |
2009-03-05 |
Protia, Llc |
Deuterium-enriched dalbavancin
|
|
US7767860B2
(en)
|
2007-09-06 |
2010-08-03 |
Auspex Pharmaceuticals, Inc |
Substituted amino alcohols
|
|
US20090069395A1
(en)
*
|
2007-09-09 |
2009-03-12 |
Protia, Llc |
Deuterium-enriched famotidine
|
|
WO2009035662A1
(en)
|
2007-09-12 |
2009-03-19 |
Concert Pharmaceuticals, Inc. |
Deuterated 4 -oxoquinoline derivatives for the treatment of hiv infection
|
|
US8669268B2
(en)
|
2007-09-12 |
2014-03-11 |
Deuterx, Llc |
Deuterium-enriched prasugrel
|
|
US8304435B2
(en)
|
2007-09-12 |
2012-11-06 |
Deuteria Pharmaceuticals Inc. |
Deuterium-enriched donepezil
|
|
US8288414B2
(en)
|
2007-09-12 |
2012-10-16 |
Deuteria Pharmaceuticals, Inc. |
Deuterium-enriched lenalidomide
|
|
WO2009035652A1
(en)
|
2007-09-13 |
2009-03-19 |
Concert Pharmaceuticals, Inc. |
Synthesis of deuterated catechols and benzo[d][1,3] dioxoles and derivatives thereof
|
|
US7919516B2
(en)
|
2007-09-13 |
2011-04-05 |
Protia, Llc |
Deuterium-enriched ondansetron
|
|
US20090076161A1
(en)
|
2007-09-13 |
2009-03-19 |
Protia, Llc |
Deuterium-enriched bupropion
|
|
US8026249B2
(en)
|
2007-09-14 |
2011-09-27 |
Deutena Pharmaceuticals, Inc. |
Deuterium-enriched topotecan
|
|
US7776866B2
(en)
|
2007-09-15 |
2010-08-17 |
Protia, Llc |
Deuterium-enriched risperidone
|
|
US7842675B2
(en)
|
2007-09-15 |
2010-11-30 |
Protia, Llc |
Deuterium-enriched capecitabine
|
|
US7956080B2
(en)
|
2007-09-25 |
2011-06-07 |
Protra, LLC |
Deuterium-enriched SDX-101
|
|
US20090082259A1
(en)
*
|
2007-09-26 |
2009-03-26 |
Protia, Llc |
Deuterium-enriched octreotide
|
|
US8722710B2
(en)
|
2007-09-26 |
2014-05-13 |
Deuterx, Llc |
Deuterium-enriched pioglitazone
|
|
US20090105338A1
(en)
*
|
2007-10-18 |
2009-04-23 |
Protia, Llc |
Deuterium-enriched gabexate mesylate
|
|
US8410124B2
(en)
*
|
2007-10-18 |
2013-04-02 |
Concert Pharmaceuticals Inc. |
Deuterated etravirine
|
|
US8592487B2
(en)
|
2007-10-26 |
2013-11-26 |
Concert Pharmaceuticals, Inc. |
Deuterated darunavir
|
|
EP2222324A2
(en)
*
|
2007-11-20 |
2010-09-01 |
Concert Pharmaceuticals, Inc. |
Boceprevir derivatives for the treatment of hcv infections
|
|
US7875610B2
(en)
*
|
2007-12-03 |
2011-01-25 |
Richter Gedeon Nyrt. |
Pyrimidinyl-piperazines useful as D3/D2 receptor ligands
|
|
WO2009076373A1
(en)
|
2007-12-10 |
2009-06-18 |
Concert Pharmaceuticals Inc. |
Heterocyclic kinase inhibitors
|
|
WO2009079637A1
(en)
|
2007-12-18 |
2009-06-25 |
Concert Pharmaceuticals, Inc. |
Tetrahydroisoquinoline derivatives
|
|
WO2009094216A1
(en)
|
2008-01-22 |
2009-07-30 |
Concert Pharmaceuticals Inc. |
Derivatives of gefitinib
|
|
US8609673B2
(en)
|
2008-01-22 |
2013-12-17 |
Concert Pharmaceuticals, Inc. |
Vandetanib derivatives
|
|
JP5496915B2
(ja)
|
2008-02-13 |
2014-05-21 |
シージーアイ ファーマシューティカルズ，インコーポレーテッド |
６−アリール−イミダゾ［１，２−ａ］ピラジン誘導体、その製造方法、及びその使用方法
|
|
CA2715760C
(en)
*
|
2008-02-21 |
2017-06-13 |
Mitsubishi Tanabe Pharma Corporation |
Solid preparation for oral administration of cariprazine hydrochloride
|
|
JP5567503B2
(ja)
|
2008-02-29 |
2014-08-06 |
コンサート ファーマシューティカルズ インコーポレイテッド |
置換キサンチン誘導体
|
|
JP2011514361A
(ja)
*
|
2008-03-14 |
2011-05-06 |
レトロトップ、 インコーポレイテッド |
同位体で置換されたリジンを用いたがん治療
|
|
JP2011518774A
(ja)
*
|
2008-03-20 |
2011-06-30 |
フォレスト・ラボラトリーズ・ホールディングス・リミテッド |
ステアロイル−ＣｏＡデサチュラーゼの阻害剤としての新規ピペリジン誘導体
|
|
JP2011525478A
(ja)
*
|
2008-03-20 |
2011-09-22 |
フォレスト・ラボラトリーズ・ホールディングス・リミテッド |
ステアロイル−ＣｏＡデサチュラーゼの阻害剤としての新規ピペラジン誘導体
|
|
US8367674B2
(en)
|
2008-04-17 |
2013-02-05 |
Concert Pharmaceuticals, Inc. |
Piperazine derivatives
|
|
WO2009148600A2
(en)
*
|
2008-06-06 |
2009-12-10 |
Concert Pharmaceuticals, Inc. |
Deuterated lysine-based compounds
|
|
WO2009154754A2
(en)
|
2008-06-17 |
2009-12-23 |
Concert Pharmaceuticals, Inc. |
Synthesis of deuterated morpholine derivatives
|
|
US20100016297A1
(en)
*
|
2008-06-24 |
2010-01-21 |
Memory Pharmaceuticals Corporation |
Alkyl-substituted 3' compounds having 5-ht6 receptor affinity
|
|
WO2009158005A1
(en)
*
|
2008-06-27 |
2009-12-30 |
Concert Pharmaceuticals, Inc. |
Benzazepinone compounds
|
|
WO2010005520A2
(en)
*
|
2008-06-30 |
2010-01-14 |
Concert Pharmaceuticals, Inc. |
2-alkyl-3-acylpyrazolo[1,5-a]pyridine derivatives
|
|
WO2010002451A1
(en)
*
|
2008-07-01 |
2010-01-07 |
Concert Pharmaceuticals, Inc. |
Naphthyridin derivatives
|
|
US20100022581A1
(en)
*
|
2008-07-02 |
2010-01-28 |
Memory Pharmaceuticals Corporation |
Pyrrolidine-substituted azaindole compounds having 5-ht6 receptor affinity
|
|
RU2509773C2
(ru)
*
|
2008-07-15 |
2014-03-20 |
Теракос, Инк. |
Дейтерированные бензилбензольные производные и способы применения
|
|
GEP20146052B
(en)
|
2008-07-16 |
2014-03-10 |
Richter Gedeon Vegyeszeti Gyar Rt |
Pharmaceutical formulations containing dopamine receptor ligands
|
|
WO2010011868A2
(en)
*
|
2008-07-23 |
2010-01-28 |
Auspex Pharmaceuticals |
Pyridine sulfonamide modulators of endothelin-a-receptor
|
|
US20100029629A1
(en)
*
|
2008-07-25 |
2010-02-04 |
Memory Pharmaceuticals Corporation |
Acyclic compounds having 5-ht6 receptor affinity
|
|
CA2732508C
(en)
|
2008-08-11 |
2016-03-15 |
Nektar Therapeutics |
Multi-arm polymeric alkanoate conjugates
|
|
US20100221221A1
(en)
*
|
2008-08-12 |
2010-09-02 |
Concert Pharmaceuticals Inc. |
N-phenyl-2-pyrimidineamine derivatives
|
|
WO2010019560A1
(en)
*
|
2008-08-12 |
2010-02-18 |
Concert Pharmaceuticals Inc. |
Deuterated derivatives of donepezil
|
|
US20100056531A1
(en)
*
|
2008-08-22 |
2010-03-04 |
Memory Pharmaceuticals Corporation |
Alkyl-substituted 3' compounds having 5-ht6 receptor affinity
|
|
US20100074973A1
(en)
*
|
2008-08-27 |
2010-03-25 |
Auspex Pharmaceuticals, Inc. |
Thioxanthene modulators of dopamine d2 receptors
|
|
EP2716158A1
(en)
|
2008-08-29 |
2014-04-09 |
Concert Pharmaceuticals Inc. |
Substituted triazolo-pyridazine derivatives
|
|
ES2633658T3
(es)
*
|
2008-09-03 |
2017-09-22 |
Teva Pharmaceutical Industries Ltd. |
Moduladores 2-oxo-1,2-dihidro-quinolina de la función inmunitaria
|
|
US8704001B2
(en)
|
2008-09-16 |
2014-04-22 |
Concert Pharmaceuticals, Inc. |
Deuterated 2-amino-3-hydroxypropanoic acid derivatives
|
|
NO3061760T3
(pt)
*
|
2008-09-18 |
2018-04-07 |
|
|
|
AU2013204067B2
(en)
*
|
2008-09-19 |
2014-02-27 |
Concert Pharmaceuticals Inc. |
Morphinan compounds
|
|
AU2015258262B2
(en)
*
|
2008-09-19 |
2016-08-18 |
Concert Pharmaceuticals Inc. |
Morphinan compounds
|
|
EP2634187B1
(en)
*
|
2008-09-19 |
2014-11-12 |
Concert Pharmaceuticals Inc. |
Deuterated morphinan compounds
|
|
WO2010036773A1
(en)
*
|
2008-09-24 |
2010-04-01 |
Concert Pharmaceuticals, Inc. |
Deuterated l-aryl-2 -aminomethyl cyclopropane carboxyamide derivatives
|
|
WO2010036796A1
(en)
*
|
2008-09-26 |
2010-04-01 |
Concert Pharmaceuticals, Inc. |
Pyridineamine derivatives
|
|
US20100113431A1
(en)
*
|
2008-11-05 |
2010-05-06 |
Auspex Pharmaceuticals, Inc. |
N-methyl piperazine modulators of h1 receptor
|
|
US20100113606A1
(en)
*
|
2008-11-05 |
2010-05-06 |
Auspex Pharmaceuticals, Inc. |
Aminopropanol modulators of beta-1 adrenergic receptor
|
|
US8227451B2
(en)
|
2008-11-12 |
2012-07-24 |
Auspex Pharmaceuticals |
Phenylacetic acid inhibitors of cyclooxygenase
|
|
US9045453B2
(en)
|
2008-11-14 |
2015-06-02 |
Concert Pharmaceuticals, Inc. |
Substituted dioxopiperidinyl phthalimide derivatives
|
|
US20100137215A1
(en)
*
|
2008-11-25 |
2010-06-03 |
Concert Pharmaceuticals Inc. |
Novel tetrahydro-1h-pyrido[4,3-b]indoles
|
|
MX2011006094A
(es)
|
2008-12-08 |
2011-11-29 |
Gilead Connecticut Inc |
Inhibidores de imidazopirazina syk.
|
|
US8450321B2
(en)
|
2008-12-08 |
2013-05-28 |
Gilead Connecticut, Inc. |
6-(1H-indazol-6-yl)-N-[4-(morpholin-4-yl)phenyl]imidazo-[1,2-A]pyrazin-8-amine, or a pharmaceutically acceptable salt thereof, as a SYK inhibitor
|
|
DK2716157T3
(en)
|
2008-12-08 |
2016-08-15 |
Gilead Connecticut Inc |
Imidazopyrazin-Syk inhibitors
|
|
HU230067B1
(hu)
|
2008-12-17 |
2015-06-29 |
Richter Gedeon Nyrt |
Új piperazin só és eljárás előállítására
|
|
HUP0800766A2
(en)
|
2008-12-18 |
2010-11-29 |
Richter Gedeon Vegyeszet |
Process for the preparation of piperazine derivatives
|
|
HUP0800765A2
(en)
|
2008-12-18 |
2010-11-29 |
Richter Gedeon Nyrt |
A new process for the preparation of piperazine derivatives and their hydrochloric salts
|
|
US8263601B2
(en)
|
2009-02-27 |
2012-09-11 |
Concert Pharmaceuticals, Inc. |
Deuterium substituted xanthine derivatives
|
|
US20110053961A1
(en)
*
|
2009-02-27 |
2011-03-03 |
Concert Pharmaceuticals, Inc. |
Substituted xanthine derivatives
|
|
EP2408771B1
(en)
|
2009-03-17 |
2016-11-16 |
Concert Pharmaceuticals, Inc. |
Pyrazinoisoquinoline compounds
|
|
WO2010118291A2
(en)
|
2009-04-10 |
2010-10-14 |
Auspex Pharmaceuticals, Inc. |
Biphenyl-3-carboxylic acid modulators of beta-3-adrenoreceptor
|
|
CN102459270B
(zh)
|
2009-04-20 |
2015-04-29 |
奥斯拜客斯制药有限公司 |
Janus激酶3的哌啶抑制剂
|
|
AU2010239244B2
(en)
|
2009-04-23 |
2014-02-27 |
Concert Pharmaceuticals, Inc. |
4-hydroxybutyric acid analogs
|
|
US20100305173A1
(en)
*
|
2009-04-30 |
2010-12-02 |
Concert Pharmaceuticals, Inc. |
Hydroxyethylamino sulfonamide derivatives
|
|
WO2010132810A1
(en)
*
|
2009-05-15 |
2010-11-18 |
Concert Pharmaceuticals, Inc. |
Deuterium modified benzimidazoles
|
|
US8410082B2
(en)
|
2009-05-22 |
2013-04-02 |
Concert Pharmaceuticals, Inc. |
Fluorinated diaryl urea derivatives
|
|
US20120244122A1
(en)
*
|
2009-05-28 |
2012-09-27 |
Masse Craig E |
Peptides for the Treatment of HCV Infections
|
|
US20110053968A1
(en)
|
2009-06-09 |
2011-03-03 |
Auspex Pharmaceuticals, Inc. |
Aminopyrimidine inhibitors of tyrosine kinase
|
|
US8586760B2
(en)
|
2009-06-15 |
2013-11-19 |
Auspex Pharmaceuticals, Inc. |
Aminothiazole modulators of beta-3-adrenoreceptor
|
|
SI2443089T1
(sl)
|
2009-06-18 |
2014-07-31 |
Concert Pharmaceuticals, Inc. |
Devterirani derivati izoindolin-1,3-diona kot inhibitorji pde4 in tnf-alfa
|
|
JP2012531419A
(ja)
|
2009-06-23 |
2012-12-10 |
コンサート ファーマシューティカルズ インコーポレイテッド |
Ｇａｂａ−ａ受容体修飾物質としての重水素修飾されたトリアゾロピリダジン誘導体
|
|
WO2011009075A2
(en)
*
|
2009-07-17 |
2011-01-20 |
Rigel Pharmaceuticals, Inc. |
Deuterated 2, 4-pyrimidinediamine compounds and prodrugs thereof and their uses
|
|
CA2768043A1
(en)
*
|
2009-07-27 |
2011-02-10 |
Auspex Pharmaceuticals, Inc. |
Cyclopropyl modulators of p2y12 receptor
|
|
US8575348B2
(en)
|
2009-07-28 |
2013-11-05 |
Auspex Pharmaceuticals, Inc |
Quinolone inhibitors of lipoprotein-associated phospholipase A2
|
|
US8637524B2
(en)
|
2009-07-28 |
2014-01-28 |
Auspex Pharmaceuticals, Inc |
Pyrimidinone inhibitors of lipoprotein-associated phospholipase A2
|
|
US9512104B2
(en)
|
2009-07-28 |
2016-12-06 |
Auspex Pharmaceuticals, Inc. |
Quinolone inhibitors of lipoprotein-associated phospholipase A2
|
|
US20110105603A1
(en)
*
|
2010-08-06 |
2011-05-05 |
American Life Science Pharmaceuticals, Inc. |
Compositions and methods for treating beta-amyloid related diseases
|
|
EP2921486B1
(en)
*
|
2009-08-07 |
2017-09-27 |
American Life Science Pharmaceuticals, Inc. |
Compositions and methods for treating beta-amyloid related diseases
|
|
US8530479B2
(en)
*
|
2009-08-10 |
2013-09-10 |
Daljit Singh Dhanoa |
Deuterium-enriched alkyl sulfonamides
|
|
EP2464355A4
(en)
|
2009-08-14 |
2013-01-02 |
Concert Pharmaceuticals Inc |
SUBSTITUTED TRIAZOLPHTHALAZINE DERIVATIVES
|
|
US8658236B2
(en)
|
2009-08-21 |
2014-02-25 |
Deuteria Beverages, Llc |
Alcoholic compositions having a lowered risk of acetaldehydemia
|
|
JP2013503883A
(ja)
|
2009-09-02 |
2013-02-04 |
コンサート ファーマシューティカルズ インコーポレイテッド |
置換キサンチン誘導体
|
|
WO2011028820A1
(en)
|
2009-09-02 |
2011-03-10 |
Concert Pharmaceuticals, Inc. |
Substituted derivatives of bicyclic [4.3.0] heteroaryl compounds
|
|
CN101666757B
(zh)
*
|
2009-09-25 |
2011-03-16 |
广东省药品检验所 |
中草药降压产品中掺杂二氢吡啶类降压化合物的快筛方法
|
|
KR20120110090A
(ko)
*
|
2009-09-28 |
2012-10-09 |
에프. 호프만-라 로슈 리미티드 |
Ｃ형 간염 바이러스 복제의 신규한 마크로시클릭 저해제
|
|
US8278460B2
(en)
|
2009-10-15 |
2012-10-02 |
Concert Pharmaceuticals, Inc. |
Substituted benzimidazoles
|
|
WO2011056511A2
(en)
|
2009-10-26 |
2011-05-12 |
Auspex Pharmaceuticals, Inc. |
4,6-diaminopyrimidine stimulators of soluble guanylate cyclase
|
|
EP2493476A4
(en)
*
|
2009-10-28 |
2013-06-19 |
Anadys Pharmaceuticals Inc |
DEUTERATED 5,6-DIHYDRO-1H-PYRIDINE-2-ON COMPOUNDS
|
|
EP2496563A4
(en)
*
|
2009-11-04 |
2013-04-03 |
Sichuan Beilike Biotechnology Ltd Liability Company |
CRYSTALLINE HYDRATES, THEIR PHARMACEUTICAL COMPOSITIONS AND METHODS OF PREPARATION AND USE
|
|
WO2011056764A1
(en)
*
|
2009-11-05 |
2011-05-12 |
Ambit Biosciences Corp. |
Isotopically enriched or fluorinated imidazo[2,1-b][1,3]benzothiazoles
|
|
US8471034B2
(en)
|
2009-11-18 |
2013-06-25 |
Concert Pharmaceuticals, Inc. |
Niacin prodrugs and deuterated versions thereof
|
|
US20110152303A1
(en)
*
|
2009-12-18 |
2011-06-23 |
Glaxosmithkline Llc |
Chemical Compounds
|
|
ES2654584T3
(es)
|
2010-01-15 |
2018-02-14 |
Suzhou Neupharma Co., Ltd |
Ciertas entidades químicas, composiciones y métodos
|
|
EP2536696A1
(en)
*
|
2010-02-18 |
2012-12-26 |
Concert Pharmaceuticals Inc. |
Pyrimidine derivatives
|
|
EP3144296A1
(en)
|
2010-03-02 |
2017-03-22 |
Concert Pharmaceuticals, Inc. |
Deuterated tetrahydronaphthalene derivatives
|
|
US8575361B2
(en)
|
2010-03-02 |
2013-11-05 |
Concert Pharmaceuticals Inc. |
Tetrahydronaphthalene derivatives
|
|
PT2545052E
(pt)
|
2010-03-11 |
2015-02-18 |
Gilead Connecticut Inc |
Inibidores da syk à base de imidazopiridinas
|
|
US8575221B2
(en)
|
2010-03-17 |
2013-11-05 |
Concert Pharmaceuticals, Inc. |
Derivatives of dimethylcurcumin
|
|
US9133123B2
(en)
|
2010-04-23 |
2015-09-15 |
Cytokinetics, Inc. |
Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their use
|
|
AR081626A1
(es)
|
2010-04-23 |
2012-10-10 |
Cytokinetics Inc |
Compuestos amino-piridazinicos, composiciones farmaceuticas que los contienen y uso de los mismos para tratar trastornos musculares cardiacos y esqueleticos
|
|
AR081331A1
(es)
|
2010-04-23 |
2012-08-08 |
Cytokinetics Inc |
Amino- pirimidinas composiciones de las mismas y metodos para el uso de los mismos
|
|
JP2013527237A
(ja)
*
|
2010-06-01 |
2013-06-27 |
オースペックス・ファーマシューティカルズ・インコーポレイテッド |
ベンゾキノロン系ｖｍａｔ２阻害剤
|
|
WO2012006070A1
(en)
*
|
2010-06-28 |
2012-01-12 |
Vertex Pharmaceuticals Incorporated |
Compounds and methods for the treatment or prevention of flavivirus infections
|
|
JP2013532181A
(ja)
|
2010-07-15 |
2013-08-15 |
イリイチ・エプシテイン オレグ |
組み合わせ医薬組成物及び胃腸管の機能的な疾患又は状態を治療する方法
|
|
PE20130398A1
(es)
|
2010-07-15 |
2013-04-10 |
Oleg Iliich Epshtein |
Un metodo para aumentar el efecto de una forma activa potenciada de un anticuerpo
|
|
US8637034B2
(en)
|
2010-07-15 |
2014-01-28 |
Oleg I. Epshtein |
Pharmaceutical compositions comprising activated-potentiated antibodies to interferon-gamma and S100 protein
|
|
US9107922B2
(en)
|
2010-07-16 |
2015-08-18 |
Concert Pharmaceuticals, Inc. |
Pyrimidinecarboxamide derivatives
|
|
DE112011102411T5
(de)
|
2010-07-21 |
2013-06-27 |
Oleg Iliich Epshtein |
Verfahren zur Behandlung von Aufmerksamkeits-Mangel-Hyperaktivitäts-Störung
|
|
US8691977B2
(en)
|
2010-08-23 |
2014-04-08 |
Neupharma, Inc. |
Certain chemical entities, compositions, and methods
|
|
WO2012027957A1
(en)
|
2010-08-28 |
2012-03-08 |
Suzhou Neupharma Co., Ltd. |
Bufalin derivatives, pharmaceutical compositions and use thereof
|
|
US9085788B2
(en)
|
2010-09-01 |
2015-07-21 |
Concert Pharmaceuticals, Inc. |
Process for preparing an enantiomerically enriched, deuterated secondary alcohol from a corresponding ketone without reducing deuterium incorporation
|
|
US9074233B2
(en)
|
2010-09-01 |
2015-07-07 |
Concert Pharmaceuticals, Inc. |
Process for preparing an enantiomerically enriched, deuterated secondary alcohol from a corresponding ketone without reducing deuterium incorporation
|
|
US9085570B2
(en)
|
2010-10-11 |
2015-07-21 |
The Board Of Trustees Of The Leland Stanford Junior University |
Substituted benzamides and their uses
|
|
US20130331443A1
(en)
|
2010-12-22 |
2013-12-12 |
Nektar Therapeutics |
Multi-arm polymeric prodrug conjugates of taxane-based compounds
|
|
US10894087B2
(en)
|
2010-12-22 |
2021-01-19 |
Nektar Therapeutics |
Multi-arm polymeric prodrug conjugates of cabazitaxel-based compounds
|
|
EP2670763B1
(en)
|
2011-02-02 |
2018-08-01 |
Suzhou Neupharma Co., Ltd |
Certain chemical entities, compositions, and methods
|
|
EP2675771B1
(en)
|
2011-02-14 |
2020-04-08 |
Concert Pharmaceuticals Inc. |
4-hydroxybutyric acid deuterated analogs
|
|
US9145390B2
(en)
|
2011-03-03 |
2015-09-29 |
Concert Pharmaceuticals, Inc. |
Derivatives of pyrazole-substituted amino-heteroaryl compounds
|
|
US8889687B2
(en)
|
2011-03-04 |
2014-11-18 |
Concert Pharmaceuticals, Inc. |
Deuterated pyrazinoisoquinoline compounds
|
|
EP2683379A4
(en)
|
2011-03-08 |
2014-10-01 |
Auspex Pharmaceuticals Inc |
SUBSTITUTED N-ARYL-PYRIDINONE
|
|
US9090585B2
(en)
|
2011-03-28 |
2015-07-28 |
Deuterx, Llc |
2,6-dioxo-3-deutero-piperdin-3-yl-isoindoline compounds
|
|
JP6092849B2
(ja)
*
|
2011-05-04 |
2017-03-08 |
バランス セラピューティックス, インコーポレイテッドBalance Therapeutics, Inc. |
ペンチレンテトラゾール誘導体
|
|
HUE047354T2
(hu)
|
2011-05-18 |
2020-04-28 |
Vertex Pharmaceuticals Europe Ltd |
Ivacaftor deuterizált származékai
|
|
PL3235812T3
(pl)
*
|
2011-05-18 |
2020-04-30 |
Vertex Pharmaceuticals (Europe) Limited |
Deuterowane pochodne iwakaftoru
|
|
US8691808B2
(en)
|
2011-05-20 |
2014-04-08 |
Influmedix, Inc. |
Antiviral compounds and their methods of use
|
|
CN103702961A
(zh)
*
|
2011-05-23 |
2014-04-02 |
赛诺菲 |
含有n-烷基的氘代化合物的制备方法
|
|
US8778223B2
(en)
|
2011-05-24 |
2014-07-15 |
Lc Vision, Llc |
Liquid crystals having cyclohexyl core structures and fluorinated tails
|
|
CN105294690B
(zh)
|
2011-06-17 |
2018-07-10 |
辉瑞抗感染公司 |
制备包括反-7-氧代-6-(磺基氧基)-1,6-二氮杂二环[3,2,1]辛烷-2-甲酰胺的杂环化合物及其盐的方法
|
|
DK3135656T3
(en)
*
|
2011-06-20 |
2019-04-23 |
H Lundbeck As |
DEUTERATED 1-PIPERAZINO-3-PHENYL INDANES FOR TREATMENT OF schizophrenia
|
|
JP6002223B2
(ja)
|
2011-08-26 |
2016-10-05 |
ニューファーマ， インコーポレイテッド |
特定の化学的実体、組成物、および方法
|
|
WO2013033250A1
(en)
|
2011-09-01 |
2013-03-07 |
Xiangping Qian |
Certain chemical entities, compositions, and methods
|
|
EP3332785B1
(en)
|
2011-09-14 |
2020-05-06 |
Neupharma, Inc. |
Certain chemical entities, compositions, and methods
|
|
EP2757885B1
(en)
|
2011-09-21 |
2017-03-15 |
Neupharma, Inc. |
Certain chemical entites, compositions, and methods
|
|
WO2013049701A1
(en)
|
2011-09-30 |
2013-04-04 |
Neupharma, Inc. |
Certain chemical entities, compositions, and methods
|
|
US9139819B2
(en)
|
2011-11-18 |
2015-09-22 |
Codexis, Inc. |
Biocatalysts for the preparation of hydroxy substituted carbamates
|
|
IL286348B2
(en)
|
2012-01-23 |
2023-04-01 |
Sage Therapeutics Inc |
Pharmaceutical preparations that include allopregnanolone
|
|
US9670180B2
(en)
|
2012-01-25 |
2017-06-06 |
Neupharma, Inc. |
Certain chemical entities, compositions, and methods
|
|
WO2013132263A1
(en)
*
|
2012-03-09 |
2013-09-12 |
Axelar Ab |
Picropodophyllin derivatives for use in therapy
|
|
EA201491606A1
(ru)
|
2012-04-05 |
2015-03-31 |
Схди Фаундейшн, Инк. |
Ингибиторы кинуренин-3-монооксигеназы, фармацевтические композиции и способы их применения
|
|
US9296732B2
(en)
|
2012-04-12 |
2016-03-29 |
The Board Of Trustees Of The Leland Stanford Junior University |
Substituted benzamides and their uses
|
|
KR20150002779A
(ko)
|
2012-04-13 |
2015-01-07 |
콘서트 파마슈티컬즈, 인크. |
치환된 크산틴 유도체
|
|
WO2013159026A1
(en)
|
2012-04-20 |
2013-10-24 |
Concert Pharmaceuticals, Inc. |
Deuterated rigosertib
|
|
WO2013165924A1
(en)
|
2012-04-29 |
2013-11-07 |
Neupharma, Inc. |
Certain chemical entities, compositions, and methods
|
|
US20150197525A1
(en)
|
2012-06-15 |
2015-07-16 |
Concert Pharmaceuticals, Inc. |
Deuterated derivatives of ruxolitinib
|
|
CN102757417B
(zh)
|
2012-06-18 |
2014-09-24 |
中国科学院广州生物医药与健康研究院 |
氘代苯并吡喃类化合物及其应用
|
|
WO2014008417A1
(en)
|
2012-07-04 |
2014-01-09 |
Concert Pharmaceuticals, Inc. |
Deuterated vercirnon
|
|
WO2014012009A1
(en)
|
2012-07-12 |
2014-01-16 |
Concert Pharmaceuticals, Inc. |
Deuterated idebenone
|
|
KR20150038486A
(ko)
|
2012-07-30 |
2015-04-08 |
콘서트 파마슈티컬즈, 인크. |
중수소화된 아이브루티닙
|
|
GB201214169D0
(en)
|
2012-08-08 |
2012-09-19 |
Biostatus Ltd |
New compounds and uses thereof
|
|
ES2717279T3
(es)
|
2012-08-17 |
2019-06-20 |
Concert Pharmaceuticals Inc |
Baricitinib deuterada
|
|
KR102305359B1
(ko)
|
2012-08-21 |
2021-09-24 |
세이지 테라퓨틱스, 인크. |
간질 또는 간질지속 상태를 치료하는 방법
|
|
WO2014031732A2
(en)
|
2012-08-22 |
2014-02-27 |
Cornell University |
Methods for inhibiting fascin
|
|
US9346800B2
(en)
|
2012-09-18 |
2016-05-24 |
Auspex Pharmaceuticals, Inc. |
Formulations pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2
|
|
US9550780B2
(en)
|
2012-09-18 |
2017-01-24 |
Auspex Pharmaceuticals, Inc. |
Formulations pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2
|
|
CN104812389B
(zh)
|
2012-09-24 |
2020-07-17 |
润新生物公司 |
某些化学实体、组合物及方法
|
|
US9643950B2
(en)
|
2012-10-22 |
2017-05-09 |
Concert Pharmaceuticals, Inc. |
Solid forms of {s-3-(4-amino-1-oxo-isoindolin-2-yl)(piperidine-3,4,4,5,5-d5)-2,6-dione}
|
|
US9725421B2
(en)
|
2012-11-12 |
2017-08-08 |
Neupharma, Inc. |
Substituted quinoxalines as B-raf kinase inhibitors
|
|
JP6146990B2
(ja)
*
|
2012-11-16 |
2017-06-14 |
コンサート ファーマシューティカルズ インコーポレイテッド |
重水素化されたｃｆｔｒ増強物質
|
|
CN103833630B
(zh)
*
|
2012-11-21 |
2018-11-13 |
顶点制药（欧洲）有限公司 |
氘化cftr增效剂
|
|
EP2935251A1
(en)
*
|
2012-12-20 |
2015-10-28 |
Concert Pharmaceuticals Inc. |
Deuterated alk inhibitors
|
|
WO2014110189A1
(en)
|
2013-01-09 |
2014-07-17 |
Concert Pharmaceuticals Inc. |
Deuterated momelotinib
|
|
JP6359563B2
(ja)
|
2013-01-14 |
2018-07-18 |
デュートルクス・リミテッド・ライアビリティ・カンパニーＤｅｕｔｅＲｘ， ＬＬＣ |
３−（５置換−４−オキソキナゾリン−３（４ｈ）−イル）−３−ジュウテロピペリジン−２，６−ジオン誘導体
|
|
MX2015009719A
(es)
*
|
2013-01-31 |
2016-08-08 |
Auspex Pharmaceuticals Inc |
Inhibidores benzoquinolona de vmat2.
|
|
GB201302368D0
(en)
*
|
2013-02-11 |
2013-03-27 |
Univ Bath |
Compound
|
|
AU2014236597A1
(en)
|
2013-03-14 |
2015-09-24 |
Deuterx, Llc |
3-(substituted-4-oxo-quinazolin-3(4H)-yl)-3-deutero-piperidine-2,6-dione derivatives
|
|
CA2941562C
(en)
|
2013-03-14 |
2021-09-21 |
Deuterx, Llc |
Deuterium-enriched 2,4-thiazolidinediones and methods of treatment
|
|
US9713330B1
(en)
|
2013-03-15 |
2017-07-25 |
Deuteria Agrochemicals, Llc |
Deuterium-enriched aldehydes
|
|
JP6670232B2
(ja)
|
2013-03-15 |
2020-03-18 |
デューテリア アグロケミカルズ, リミテッド ライアビリティー カンパニーDeuteria Agrochemicals, LLC |
重水素富化アルデヒド
|
|
EP2968268B1
(en)
|
2013-03-15 |
2020-07-29 |
Concert Pharmaceuticals Inc. |
Inhibitors of the enzyme udp-glucose: n-acyl-sphingosine glucosyltransferase
|
|
CN104109149B
(zh)
|
2013-04-22 |
2018-09-28 |
苏州泽璟生物制药有限公司 |
氘代的二氨基嘧啶化合物以及包含该化合物的药物组合物
|
|
EP3027171B1
(en)
|
2013-07-30 |
2020-03-25 |
Gilead Connecticut, Inc. |
Formulation of syk inhibitors
|
|
MY176803A
(en)
|
2013-07-30 |
2020-08-21 |
Gilead Connecticut Inc |
Polymorph of syk inhibitors
|
|
KR102339228B1
(ko)
|
2013-08-23 |
2021-12-13 |
뉴파마, 인크. |
특정 화학 물질, 조성물, 및 방법
|
|
US9676790B2
(en)
|
2013-08-30 |
2017-06-13 |
Concert Pharmaceuticals, Inc. |
Substituted thienotriazolodiazapines
|
|
CA2932610C
(en)
|
2013-12-03 |
2023-08-22 |
Intra-Cellular Therapies, Inc. |
Heterocycle fused gamma-carboline compounds for use in treatment of schizophrenia
|
|
CA2930744A1
(en)
|
2013-12-03 |
2015-06-11 |
Auspex Pharmaceuticals, Inc. |
Methods of manufacturing benzoquinoline compounds
|
|
DK3076976T3
(da)
|
2013-12-04 |
2020-12-07 |
Kronos Bio Inc |
Fremgangsmåder til behandling af cancer
|
|
US9732031B2
(en)
|
2013-12-20 |
2017-08-15 |
Deuterx, Llc |
Methods of treating neurological and other disorders using enantiopure deuterium-enriched bupropion
|
|
US9290505B2
(en)
|
2013-12-23 |
2016-03-22 |
Gilead Sciences, Inc. |
Substituted imidazo[1,2-a]pyrazines as Syk inhibitors
|
|
TWI662037B
(zh)
|
2013-12-23 |
2019-06-11 |
美商基利科學股份有限公司 |
脾酪胺酸激酶抑制劑
|
|
US9611252B2
(en)
|
2013-12-30 |
2017-04-04 |
Lifesci Pharmaceuticals, Inc. |
Therapeutic inhibitory compounds
|
|
KR20160106627A
(ko)
|
2013-12-30 |
2016-09-12 |
라이프에스씨아이 파마슈티컬스, 인크. |
치료적 억제 화합물
|
|
WO2015109037A1
(en)
|
2014-01-15 |
2015-07-23 |
Deuterx, Llc |
Methods of treating neurological, metabolic, and other disorders using enantiopure deuterium-enriched pioglitazone
|
|
JP6526060B2
(ja)
*
|
2014-02-10 |
2019-06-05 |
コンサート ファーマシューティカルズ インコーポレイテッド |
置換トリアゾロベンゾジアゼピン
|
|
ES2868882T3
(es)
|
2014-02-20 |
2021-10-22 |
Cornell Univ Cornell Center For Technology Enterprise & Commercialization Cctec |
Compuestos y métodos para inhibir fascina
|
|
PL3125893T3
(pl)
*
|
2014-04-04 |
2024-02-12 |
Intra-Cellular Therapies, Inc. |
Deuterowane gamma-karboliny w fuzji z heterocyklami jako antagoniści receptorów 5-HT2A
|
|
JP6810613B2
(ja)
*
|
2014-06-20 |
2021-01-06 |
イントラ−セルラー・セラピーズ・インコーポレイテッドＩｎｔｒａ−Ｃｅｌｌｕｌａｒ Ｔｈｅｒａｐｉｅｓ， Ｉｎｃ． |
有機化合物
|
|
MA40075A
(fr)
|
2014-07-14 |
2016-01-21 |
Gilead Sciences Inc |
Combinaisons pour traiter des cancers
|
|
PL3193611T3
(pl)
|
2014-09-17 |
2021-10-04 |
Celgene Car Llc |
Inhibitory mk2 i ich zastosowania
|
|
US10160778B2
(en)
|
2014-10-27 |
2018-12-25 |
Concert Pharmaceuticals, Inc. |
Pyrimidine phosphonic acid esters
|
|
WO2016065930A1
(en)
*
|
2014-10-29 |
2016-05-06 |
Center Laboratories, Inc. |
Crystal forms of verapamil hydrochloride
|
|
BR112017009657A2
(pt)
|
2014-11-06 |
2018-01-23 |
Enanta Pharmaceuticals, Inc |
análogos de ácidos biliares como agonistas de fxr/tgr5 e métodos de uso dos mesmos
|
|
US11578097B2
(en)
|
2014-11-26 |
2023-02-14 |
Enanta Pharmaceuticals, Inc. |
Tetrazole derivatives of bile acids as FXR/TGR5 agonists and methods of use thereof
|
|
US10208081B2
(en)
|
2014-11-26 |
2019-02-19 |
Enanta Pharmaceuticals, Inc. |
Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
|
|
US20160214918A1
(en)
*
|
2015-01-22 |
2016-07-28 |
Kaohsiung Medical University |
Composition for treating metabolic syndrome and a preparation method thereof
|
|
CN105985396A
(zh)
*
|
2015-02-16 |
2016-10-05 |
苏州泽璟生物制药有限公司 |
氘代鹅去氧胆酸衍生物以及包含该化合物的药物组合物
|
|
CN107613769A
(zh)
|
2015-02-17 |
2018-01-19 |
润新生物公司 |
某些化学实体、组合物和方法
|
|
WO2016144901A1
(en)
|
2015-03-06 |
2016-09-15 |
Auspex Pharmaceuticals, Inc. |
Methods for the treatment of abnormal involuntary movement disorders
|
|
EP3277647A1
(en)
|
2015-03-31 |
2018-02-07 |
Vertex Pharmaceuticals (Europe) Limited |
Deuterated vx-661
|
|
LT3277286T
(lt)
|
2015-03-31 |
2021-07-26 |
Enanta Pharmaceuticals, Inc. |
Tulžies rūgšties dariniai kaip fxr/tgr agonistai, ir jų panaudojimo būdai
|
|
WO2016164763A1
(en)
*
|
2015-04-10 |
2016-10-13 |
Sage Therapeutics, Inc. |
Compositions and methods for treating cns disorders
|
|
US10683305B2
(en)
|
2015-04-27 |
2020-06-16 |
Concert Pharmaceuticals, Inc. |
Deuterated OTX-015
|
|
CN106279039B
(zh)
*
|
2015-06-02 |
2019-01-11 |
青岛海洋生物医药研究院股份有限公司 |
氘代脱氢苯基阿夕斯丁类化合物及其制备方法和在制备抗肿瘤的药物中的应用
|
|
WO2017001926A2
(en)
|
2015-07-01 |
2017-01-05 |
Lifesci Pharmaceuticals, Inc |
Therapeutic inhibitory compounds
|
|
US9809603B1
(en)
|
2015-08-18 |
2017-11-07 |
Deuterx, Llc |
Deuterium-enriched isoindolinonyl-piperidinonyl conjugates and oxoquinazolin-3(4H)-yl-piperidinonyl conjugates and methods of treating medical disorders using same
|
|
US10759721B2
(en)
|
2015-09-25 |
2020-09-01 |
Vertex Pharmaceuticals (Europe) Limited |
Deuterated CFTR potentiators
|
|
WO2017083431A2
(en)
|
2015-11-09 |
2017-05-18 |
Forge Therapeutics, Inc. |
Hydroxypyridinone and hydroxypyrimidinone based compounds for treating bacterial infections
|
|
US11267777B2
(en)
|
2015-11-19 |
2022-03-08 |
Concert Pharmaceuticals, Inc. |
Deuterated EPI-743
|
|
WO2017100305A2
(en)
|
2015-12-07 |
2017-06-15 |
Opi Vi - Ip Holdco Llc |
Composition of antibody construct-agonist conjugates and methods of use thereof
|
|
CN106892924B
(zh)
*
|
2015-12-17 |
2021-01-08 |
四川科伦博泰生物医药股份有限公司 |
短效苯并二氮*衍生物、其制备方法及其用途
|
|
EP3416629A4
(en)
|
2016-02-16 |
2019-08-07 |
CoNCERT Pharmaceuticals, Inc. |
DEUTERATED GFT-505
|
|
US10364267B2
(en)
*
|
2016-02-23 |
2019-07-30 |
Enanta Pharmaceuticals, Inc. |
Deuterated bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
|
|
EP3398942B1
(en)
*
|
2016-02-25 |
2021-01-27 |
Shenzhen TargetRx, Inc. |
Substituted oxadiazole chemical compound and composition containing said chemical compound and use thereof
|
|
RU2766155C2
(ru)
|
2016-03-08 |
2022-02-08 |
Сейдж Терапьютикс, Инк. |
Нейроактивные стероиды, их композиции и применения
|
|
JP6686168B2
(ja)
|
2016-03-25 |
2020-04-22 |
イントラ−セルラー・セラピーズ・インコーポレイテッドＩｎｔｒａ−Ｃｅｌｌｕｌａｒ Ｔｈｅｒａｐｉｅｓ， Ｉｎｃ． |
有機化合物
|
|
US11274087B2
(en)
|
2016-07-08 |
2022-03-15 |
Richter Gedeon Nyrt. |
Industrial process for the preparation of cariprazine
|
|
WO2018011628A1
(en)
|
2016-07-11 |
2018-01-18 |
Lifesci Pharmaceuticals, Inc. |
Therapeutic inhibitory compounds
|
|
CA3033370A1
(en)
|
2016-08-15 |
2018-02-22 |
Neupharma, Inc. |
Certain chemical entities, compositions, and methods
|
|
CN109843869B
(zh)
*
|
2016-09-29 |
2021-07-16 |
江苏吉贝尔药业股份有限公司 |
1-[(吡啶-3-基-磺酰基)-1h-吡咯-3-基]甲胺衍生物及其药物组合物和用途
|
|
CN110072518B
(zh)
|
2016-10-12 |
2021-10-26 |
细胞内治疗公司 |
无定形固体分散体
|
|
JP2017105824A
(ja)
*
|
2017-02-10 |
2017-06-15 |
コンサート ファーマシューティカルズ インコーポレイテッド |
重水素化されたｃｆｔｒ増強物質
|
|
WO2018170179A1
(en)
|
2017-03-15 |
2018-09-20 |
Silverback Therapeutics, Inc. |
Benzazepine compounds, conjugates, and uses thereof
|
|
WO2018170201A1
(en)
|
2017-03-16 |
2018-09-20 |
Celgene Car Llc |
Deuterated analogs of mk2 inhibitors and uses thereof
|
|
WO2018170200A1
(en)
*
|
2017-03-16 |
2018-09-20 |
Celgene Car Llc |
Heteroaryl compounds useful as mk2 inhibitors
|
|
EP3596084A4
(en)
|
2017-03-16 |
2020-12-23 |
Celgene CAR LLC |
9,10,11,12-TETRAHYDRO-8H- [1,4] DIAZEPINO [5 ', 6': 4.5] THIENO [3,2-F] QUINOLINE-8-ON COMPOUNDS AND USES THEREOF
|
|
JP7132939B2
(ja)
|
2017-03-24 |
2022-09-07 |
イントラ－セルラー・セラピーズ・インコーポレイテッド |
新規組成物および方法
|
|
US11021471B2
(en)
|
2017-05-10 |
2021-06-01 |
Forge Therapeutics, Inc. |
Antibacterial compounds
|
|
JP2020522504A
(ja)
|
2017-06-01 |
2020-07-30 |
エックスオーシー ファーマシューティカルズ インコーポレイテッドＸｏｃ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ |
多環式化合物およびそれらの用途
|
|
CN107226769A
(zh)
*
|
2017-06-19 |
2017-10-03 |
郑州泰基鸿诺医药股份有限公司 |
一种含二氟氘代甲氧（硫）基官能团的芳香类化合物的合成方法
|
|
CN109422731A
(zh)
*
|
2017-08-24 |
2019-03-05 |
正大天晴药业集团股份有限公司 |
氘代喹啉衍生物
|
|
CN111051311A
(zh)
|
2017-08-25 |
2020-04-21 |
吉利德科学公司 |
Syk抑制剂的多晶型物
|
|
CN108947974B
(zh)
|
2017-08-30 |
2020-06-05 |
深圳市塔吉瑞生物医药有限公司 |
一种氨基嘧啶类化合物及包含该化合物的组合物及其用途
|
|
WO2019084060A1
(en)
|
2017-10-24 |
2019-05-02 |
Silverback Therapeutics, Inc. |
CONJUGATES AND METHODS OF USE FOR THE SELECTIVE DELIVERY OF IMMUNOMODULATORY AGENTS
|
|
US20230192625A1
(en)
*
|
2017-11-14 |
2023-06-22 |
Shenzhen Targetrx, Inc. |
Substituted benzimidazole compound and composition comprising same
|
|
CA3082834A1
(en)
|
2017-11-22 |
2019-05-31 |
Concert Pharmaceuticals, Inc. |
Deuterated analogs of d-serine and uses thereof
|
|
BR112020010335A2
(pt)
|
2017-12-01 |
2020-11-10 |
Vertex Pharmaceuticals Incorporated |
processos para produzir moduladores de regulador de condutância de transmembrana de fibrose cística
|
|
MA51046A
(fr)
*
|
2017-12-08 |
2021-03-17 |
Sage Therapeutics Inc |
Dérivés de 21-[4-cyano-pyrazol-1-yl]-19-nor-pregan-3. alpha-ol-20-one deutérés pour le traitement de troubles du snc
|
|
TWI780281B
(zh)
*
|
2017-12-14 |
2022-10-11 |
丹麥商Ｎｍｄ藥品公司 |
用於治療神經肌肉病症的化合物
|
|
KR20200100113A
(ko)
|
2017-12-15 |
2020-08-25 |
실버백 테라퓨틱스, 인크. |
간염 치료용 항체 구조물-약물 접합체
|
|
CN109456331B
(zh)
*
|
2017-12-22 |
2020-06-05 |
深圳市塔吉瑞生物医药有限公司 |
一种取代的吡唑并[1,5-a]嘧啶化合物及其药物组合物及用途
|
|
CA3087283A1
(en)
|
2018-01-19 |
2019-07-25 |
Cytokinetics, Inc. |
Dihydrobenzofuran and inden analogs as cardiac sarcomere inhibitors
|
|
JP7162915B2
(ja)
|
2018-01-23 |
2022-10-31 |
深▲チェン▼市塔吉瑞生物医薬有限公司 |
置換ピラゾロ［１，５－ａ］ピリミジン系大環状化合物
|
|
US11453676B2
(en)
|
2018-02-02 |
2022-09-27 |
Forward Therapeutics, Inc. |
Inhibitors of protein arginine deiminases
|
|
CA3090528A1
(en)
|
2018-02-08 |
2019-08-15 |
Neupharma, Inc. |
Certain chemical entities, compositions, and methods
|
|
EP3768255A4
(en)
*
|
2018-03-21 |
2021-12-22 |
Izumi Technology, LLC |
DEUTERED ANALOGA OF ELACRIDAR
|
|
WO2019195278A1
(en)
|
2018-04-02 |
2019-10-10 |
Silverback Therapeutics, Inc. |
Alk5 inhibitors, conjugates, and uses thereof
|
|
EP3787629A4
(en)
|
2018-05-02 |
2022-01-05 |
Kinnate Biopharma Inc. |
INHIBITORS OF CYCLINE-DEPENDENT KINASES
|
|
SG11202011703VA
(en)
|
2018-05-25 |
2020-12-30 |
Silverback Therapeutics Inc |
Amino-pyrazinecarboxamide compounds, conjugates, and uses thereof
|
|
WO2020005887A1
(en)
|
2018-06-26 |
2020-01-02 |
Cytokinetics, Inc. |
Cardiac sarcomere inhibitors
|
|
WO2020005888A1
(en)
|
2018-06-26 |
2020-01-02 |
Cytokinetics, Inc. |
Cardiac sarcomere inhibitors
|
|
AR115646A1
(es)
|
2018-06-29 |
2021-02-10 |
Kinnate Biopharma Inc |
Inhibidores de quinasas dependientes de ciclinas
|
|
JP6654223B2
(ja)
*
|
2018-08-13 |
2020-02-26 |
バーテックス ファーマシューティカルズ （ヨーロッパ） リミテッド |
重水素化されたｃｆｔｒ増強物質
|
|
CN109020875B
(zh)
*
|
2018-08-27 |
2020-05-22 |
北京市药品检验所 |
二氢吡啶类化合物脱氢芳构化方法及在药品检测中的用途
|
|
US11957791B2
(en)
|
2018-08-31 |
2024-04-16 |
Intra-Cellular Therapies, Inc. |
Methods
|
|
CN112584838A
(zh)
|
2018-08-31 |
2021-03-30 |
细胞内治疗公司 |
新方法
|
|
SG11202101769YA
(en)
|
2018-08-31 |
2021-03-30 |
Cytokinetics Inc |
Cardiac sarcomere inhibitors
|
|
JP2021536488A
(ja)
*
|
2018-09-05 |
2021-12-27 |
ルパン インコーポレイテッド |
細菌性膣症の治療に使用するための重水素化セクニダゾールならびにその方法および使用
|
|
EP3849971A2
(en)
|
2018-09-12 |
2021-07-21 |
Silverback Therapeutics, Inc. |
Substituted benzazepine compounds, conjugates, and uses thereof
|
|
WO2020056194A1
(en)
|
2018-09-12 |
2020-03-19 |
Silverback Therapeutics, Inc. |
Benzazepine compounds, conjugates, and uses thereof
|
|
JP2022500414A
(ja)
|
2018-09-12 |
2022-01-04 |
シルバーバック セラピューティックス インコーポレイテッド |
免疫刺激性コンジュゲートにより疾患を処置する方法および組成物
|
|
CN113166077A
(zh)
|
2018-09-20 |
2021-07-23 |
福至治疗公司 |
抗细菌化合物
|
|
MA53932A
(fr)
|
2018-10-16 |
2021-08-25 |
Glo Pharma Inc |
Compositions de conotoxine servant d'antagonistes peptidiques des récepteurs nicotiniques de l'acétylcholine et méthodes associées
|
|
EP3877052B1
(en)
|
2018-11-06 |
2023-08-16 |
Edgewise Therapeutics, Inc. |
Pyridazinone compounds and uses thereof
|
|
SG11202104713RA
(en)
|
2018-11-06 |
2021-06-29 |
Edgewise Therapeutics Inc |
Pyridazinone compounds and uses thereof
|
|
AU2019374812A1
(en)
|
2018-11-06 |
2021-06-10 |
Edgewise Therapeutics, Inc. |
Pyridazinone compounds and uses thereof
|
|
JP2022509965A
(ja)
|
2018-12-03 |
2022-01-25 |
ハー・ルンドベック・アクチエゼルスカベット |
４－（（１Ｒ，３Ｓ）－６－クロロ－３－フェニル－２，３－ジヒドロ－１Ｈ－インデン－１－イル）－１，２，２－トリメチルピペラジン及び４－（（１Ｒ，３Ｓ）－６－クロロ－３－（フェニル－ｄ５）－２，３－ジヒドロ－１Ｈ－インデン－１－イル）－２，２－ジメチル－１－（メチル－ｄ３）ピペラジンのプロドラッグ
|
|
EP3886986A1
(en)
*
|
2018-12-06 |
2021-10-06 |
IntraBio Ltd |
Deuterated analogs of acetyl-leucine
|
|
AR117228A1
(es)
*
|
2018-12-06 |
2021-07-21 |
Arisan Therapeutics |
DERIVADOS DE PIRAZOLO[1,2-a]PIRIDINA, 1H-BENZO[d][1,2,3]TRIAZOL, IMIDAZOPIRIMIDINA Y BENCIMIDAZOL PARA USAR EN EL TRATAMIENTO DE LA INFECCIÓN POR ARENAVIRUS
|
|
JP7061236B2
(ja)
|
2019-01-22 |
2022-04-27 |
エオビアン ファーマシューティカルズ， インコーポレイテッド |
Ｍｔｏｒｃモジュレーターおよびその使用
|
|
KR20210132104A
(ko)
|
2019-02-19 |
2021-11-03 |
울티마 제노믹스, 인크. |
광학 검출 및 시퀀싱을 위한 링커 및 방법
|
|
MX2021010131A
(es)
|
2019-02-22 |
2021-11-18 |
Kronos Bio Inc |
Formas sólidas de pirazinas condensadas a manera de inhibidores de syk.
|
|
CA3131104A1
(en)
|
2019-03-06 |
2020-09-10 |
Silverback Therapeutics, Inc. |
Cyclic amino-pyrazinecarboxamide compounds and uses thereof
|
|
US11547707B2
(en)
|
2019-04-10 |
2023-01-10 |
Richter Gedeon Nyrt. |
Carbamoyl cyclohexane derivatives for treating autism spectrum disorder
|
|
JP2022530322A
(ja)
|
2019-04-18 |
2022-06-29 |
アズーラ オフサルミックス エルティーディー． |
眼障害を処置するための化合物および方法
|
|
EP3955937A4
(en)
|
2019-04-18 |
2023-01-18 |
Azura Ophthalmics Ltd. |
COMPOUNDS AND METHODS FOR TREATING EYE DISORDERS
|
|
TW202106684A
(zh)
|
2019-05-03 |
2021-02-16 |
美商奇奈特生物製藥公司 |
Raf激酶抑制劑
|
|
WO2020226628A1
(en)
|
2019-05-07 |
2020-11-12 |
Nirsum Laboratories, Inc. |
Opioid receptor antagonist prodrugs for treating opioid dependence
|
|
WO2020247540A1
(en)
|
2019-06-03 |
2020-12-10 |
Biointervene, Inc. |
Adenosine analogs for the treatment of disease
|
|
WO2020247546A1
(en)
|
2019-06-03 |
2020-12-10 |
Biointervene, Inc. |
Adenosine analogs for the treatment of disease
|
|
JP2022540818A
(ja)
|
2019-07-08 |
2022-09-20 |
ビーライト バイオ，エルエルシー |
Ｒｂｐ４阻害剤の製剤および使用の方法
|
|
US20210139477A1
(en)
|
2019-07-16 |
2021-05-13 |
Silverback Therapeutics, Inc. |
Alk5 inhibitors, conjugates, and uses thereof
|
|
WO2021055376A1
(en)
|
2019-09-16 |
2021-03-25 |
Dice Alpha, Inc. |
Il-17a modulators and uses thereof
|
|
CA3151322A1
(en)
|
2019-10-01 |
2021-04-08 |
Silverback Therapeutics, Inc. |
Combination therapy with immune stimulatory conjugates
|
|
KR20220150270A
(ko)
|
2019-10-07 |
2022-11-10 |
칼리오페, 인크. |
Gpr119 효능제
|
|
WO2021072330A1
(en)
|
2019-10-09 |
2021-04-15 |
Silverback Therapeutics, Inc. |
Galnac-tgfbr1 inhibitor conjugates for the treatment of liver diseases
|
|
WO2021072203A1
(en)
|
2019-10-09 |
2021-04-15 |
Silverback Therapeutics, Inc. |
Tgfbetar1 inhibitor-asgr antibody conjugates and uses thereof
|
|
US11098031B1
(en)
|
2019-10-24 |
2021-08-24 |
Kinnate Biopharma Inc. |
Inhibitors of RAF kinases
|
|
WO2021102332A1
(en)
|
2019-11-22 |
2021-05-27 |
Silverback Therapeutics, Inc. |
Tgfbetar2 inhibitor-lrrc15 antibody conjugates and uses thereof
|
|
TW202134245A
(zh)
|
2019-12-05 |
2021-09-16 |
美商邊際分析公司 |
稠合三環雜環化合物及其用途
|
|
BR112022013488A2
(pt)
|
2020-01-13 |
2022-09-13 |
Verge Analytics Inc |
Pirazolo-pirimidinas substituídas e seu uso
|
|
MX2022009771A
(es)
|
2020-02-07 |
2022-08-25 |
Cytokinetics Inc |
Moduladores de nampt.
|
|
US11807851B1
(en)
|
2020-02-18 |
2023-11-07 |
Ultima Genomics, Inc. |
Modified polynucleotides and uses thereof
|
|
JP2023514727A
(ja)
|
2020-02-21 |
2023-04-07 |
シルバーバック セラピューティックス インコーポレイテッド |
ネクチン－４抗体コンジュゲートおよびその使用
|
|
TW202140496A
(zh)
|
2020-03-09 |
2021-11-01 |
美商邊際分析公司 |
經取代嘧啶及其用途
|
|
US11731962B2
(en)
|
2020-03-25 |
2023-08-22 |
Blacksmith Medicines, Inc. |
LpxC inhibitor and methods of making
|
|
AU2021268606A1
(en)
|
2020-05-04 |
2022-12-15 |
Volastra Therapeutics, Inc. |
Imino sulfanone inhibitors of ENPP1
|
|
IL297914A
(en)
|
2020-05-06 |
2023-01-01 |
Cytokinetics Inc |
Nampet Modulators
|
|
WO2021231615A1
(en)
|
2020-05-13 |
2021-11-18 |
Edgewise Therapeutics, Inc. |
Substituted pyridazinone for use in the treatment of neuromuscular diseases
|
|
EP4149465A1
(en)
|
2020-05-13 |
2023-03-22 |
Edgewise Therapeutics, Inc. |
Substituted pyridazinone for use in the treatment of neuromuscular diseases
|
|
JP2023526248A
(ja)
|
2020-05-13 |
2023-06-21 |
エッジワイズ セラピューティクス， インコーポレイテッド |
神経筋疾患の処置のためのピリダジノン化合物
|
|
EP4149466A1
(en)
|
2020-05-13 |
2023-03-22 |
Edgewise Therapeutics, Inc. |
Substituted pyridazinone for use in the treatment of neuromuscular diseases
|
|
EP4149621A1
(en)
|
2020-05-13 |
2023-03-22 |
Edgewise Therapeutics, Inc. |
Pyridazinone compounds for the treatment of neuromuscular diseases
|
|
JP2023526050A
(ja)
|
2020-05-14 |
2023-06-20 |
ヴィア・バイオテクノロジー・インコーポレイテッド |
Ｅｎｐｐ１モジュレーターおよびその使用
|
|
AU2021275038A1
(en)
|
2020-05-19 |
2022-12-22 |
Kallyope, Inc. |
AMPK activators
|
|
CN116057045A
(zh)
|
2020-06-05 |
2023-05-02 |
金耐特生物制药公司 |
成纤维细胞生长因子受体激酶抑制剂
|
|
US20230036933A1
(en)
|
2020-06-16 |
2023-02-02 |
Volastra Therapeutics, Inc. |
Heterocyclic inhibitors of enpp1
|
|
WO2021263039A1
(en)
|
2020-06-26 |
2021-12-30 |
Kallyope, Inc. |
Ampk activators
|
|
US11319313B2
(en)
|
2020-06-30 |
2022-05-03 |
Poxel Sa |
Crystalline forms of deuterium-enriched pioglitazone
|
|
US11767317B1
(en)
|
2020-06-30 |
2023-09-26 |
Poxel Sa |
Methods of synthesizing enantiopure deuterium-enriched pioglitazone
|
|
IL299508A
(en)
|
2020-07-01 |
2023-02-01 |
Ars Pharmaceuticals Inc |
Name of the invention: antibody conjugates against ASGR1 and their uses
|
|
CN116322677A
(zh)
|
2020-07-21 |
2023-06-23 |
艾奥维安制药公司 |
Mtorc1调节剂及其用途
|
|
AU2021328349A1
(en)
|
2020-08-17 |
2023-03-16 |
Biointervene, Inc. |
A3 adenosine receptor agonists for use in medicine
|
|
KR102666349B1
(ko)
*
|
2020-08-27 |
2024-05-16 |
주식회사 엘지화학 |
중수소화 방향족 화합물의 제조 방법 및 중수소화 반응 조성물
|
|
CN111995574B
(zh)
*
|
2020-08-28 |
2024-05-17 |
西安明喆药品生产有限公司 |
氘代羟氯喹衍生物以及包含该化合物的药物组合物
|
|
WO2022060996A1
(en)
|
2020-09-18 |
2022-03-24 |
Kinnate Biopharma Inc. |
Inhibitors of raf kinases
|
|
WO2022081469A1
(en)
|
2020-10-12 |
2022-04-21 |
Kinnate Biopharma Inc. |
Inhibitors of raf kinases
|
|
CA3176635A1
(en)
|
2020-11-06 |
2022-05-12 |
Cytokinetics, Inc. |
Bicyclic 1,4-diazepanones and therapeutic uses thereof
|
|
AU2021381012A1
(en)
|
2020-11-20 |
2023-06-22 |
2692372 Ontario, Inc. |
Methods and composition for kras modifications
|
|
CA3198342A1
(en)
|
2020-11-20 |
2022-05-27 |
Patric T. Gunning |
Benzenesulfonamide derivatives and uses thereof
|
|
JP2024501233A
(ja)
|
2020-12-21 |
2024-01-11 |
サイトキネティックス， インコーポレイテッド |
Ｎａｍｐｔモジュレーターとして有用なピラゾール誘導体
|
|
WO2022169882A1
(en)
|
2021-02-03 |
2022-08-11 |
Verge Analytics, Inc. |
Methods and treatment of viral infection caused by sars-cov-2
|
|
KR20230153407A
(ko)
|
2021-02-24 |
2023-11-06 |
인실리코 메디신 아이피 리미티드 |
질환의 치료를 위한 유사체
|
|
MX2023010125A
(es)
|
2021-03-04 |
2023-09-11 |
Cytokinetics Inc |
Inhibidores del sarcomero cardiaco.
|
|
US11459351B1
(en)
|
2021-04-05 |
2022-10-04 |
Azura Ophthalmics Ltd. |
Compounds and methods for the treatment of ocular disorders
|
|
WO2022217118A1
(en)
|
2021-04-09 |
2022-10-13 |
Quanta Therapeutics, Inc. |
Pyrimidine based ras modulators and uses thereof
|
|
AU2022261117A1
(en)
|
2021-04-23 |
2023-11-23 |
Kinnate Biopharma Inc. |
Treatment of cancer with a raf inhibitor
|
|
JP2024516174A
(ja)
*
|
2021-04-23 |
2024-04-12 |
ギルガメッシュ・ファーマシューティカルズ・インコーポレイテッド |
新規エルゴリン及び気分障害を処置する方法
|
|
TW202313619A
(zh)
|
2021-06-01 |
2023-04-01 |
美商邊際分析公司 |
稠合雙環雜環化合物及其用途
|
|
WO2022256297A1
(en)
|
2021-06-01 |
2022-12-08 |
Verge Analytics, Inc. |
2-(3-phenyl-1h-pyrazol-1-yl)-4-morpholino-5h-pyrrolo[3,2-d]pyrimidine derivatives and similar compounds as pikfyve kinase inhibitors for the treatment of e.g. amyotrophic lateral sclerosis (als)
|
|
WO2022256298A1
(en)
|
2021-06-01 |
2022-12-08 |
Verge Analytics, Inc. |
7-(3-phenyl-1 h-pyrazol-1-yl)-5-morpholino-imidazo[1,2-a]pyrimidine derivatives and similar compounds as pikfyve kinase inhibitors for the treatment of e.g. amyotrophic lateral sclerosis (als)
|
|
WO2022256299A1
(en)
|
2021-06-01 |
2022-12-08 |
Verge Analytics, Inc. |
7-morpholino-5-(3-phenyl-1 h-pyrazol-1 -yl)-furo[3,2-b]pyridine derivatives and similar compounds as pikfyve kinase inhibitors for the treatment of e.g. amyotrophic lateral sclerosis (als)
|
|
TW202313051A
(zh)
|
2021-06-08 |
2023-04-01 |
美商邊際分析公司 |
使用經取代呋喃并嘧啶之病毒感染治療及方法
|
|
WO2022263829A1
(en)
|
2021-06-16 |
2022-12-22 |
Z Factor Limited |
COMPOUNDS AND THEIR USE FOR THE TREATMENT OF α1-ANTITRYPSIN DEFICIENCY
|
|
AU2022298746A1
(en)
|
2021-06-24 |
2023-11-30 |
Insilico Medicine Ip Limited |
Beta-lactam derivatives for the treatment of diseases
|
|
CA3224467A1
(en)
|
2021-07-09 |
2023-01-12 |
Dice Alpha, Inc. |
Phenyl acetamide based il-17a modulators and uses thereof
|
|
EP4370512A1
(en)
|
2021-07-12 |
2024-05-22 |
Cytokinetics, Inc. |
Cd38 modulators and methods of use thereof
|
|
WO2023028564A1
(en)
|
2021-08-26 |
2023-03-02 |
Volastra Therapeutics, Inc. |
Spiro indoline inhibitors of kif18a
|
|
WO2023070114A2
(en)
|
2021-10-22 |
2023-04-27 |
Terremoto Biosciences, Inc. |
Reversible lysine covalent modifiers of egfr and uses thereof
|
|
WO2023076866A1
(en)
|
2021-10-25 |
2023-05-04 |
Volastra Therapeutics, Inc. |
Tricyclic sulfoximine inhibitors of enpp1
|
|
WO2023081312A1
(en)
|
2021-11-04 |
2023-05-11 |
Vir Biotechnology, Inc. |
Small molecule inducers of autophagy
|
|
AR127646A1
(es)
|
2021-11-12 |
2024-02-14 |
Insilico Medicine Ip Ltd |
Inhibidores de molécula pequeña de proteasa 1 específica de ubiquitina (usp1) y usos de los mismos
|
|
WO2023086638A1
(en)
|
2021-11-15 |
2023-05-19 |
Vir Biotechnology, Inc. |
Enpp1 modulators and uses thereof
|
|
WO2023091606A1
(en)
|
2021-11-17 |
2023-05-25 |
Edgewise Therapeutics, Inc. |
Pyridazinone compounds and uses thereof
|
|
WO2023114733A1
(en)
|
2021-12-13 |
2023-06-22 |
Quanta Therapeutics, Inc. |
Kras modulators and uses thereof
|
|
WO2023114428A1
(en)
|
2021-12-16 |
2023-06-22 |
Vir Biotechnology, Inc. |
Heterocycle derivatives for the treatment of disease
|
|
CA3240907A1
(en)
|
2021-12-16 |
2023-06-22 |
Xiaohu S. OUYANG |
Inhibitors of met kinase
|
|
WO2023150681A1
(en)
|
2022-02-03 |
2023-08-10 |
Kinnate Biopharma Inc. |
Inhibitors of raf kinases
|
|
WO2023154766A1
(en)
|
2022-02-09 |
2023-08-17 |
Quanta Therapeutics, Inc. |
Kras modulators and uses thereof
|
|
WO2023164057A1
(en)
|
2022-02-25 |
2023-08-31 |
Dice Alpha, Inc. |
Di-cyclopropyl based il-17a modulators and uses thereof
|
|
WO2023168291A1
(en)
|
2022-03-02 |
2023-09-07 |
Terremoto Biosciences, Inc. |
Covalent modifiers of akt1 and uses thereof
|
|
TW202342018A
(zh)
|
2022-03-04 |
2023-11-01 |
美商奇奈特生物製藥公司 |
Mek激酶抑制劑
|
|
US11879125B2
(en)
|
2022-03-16 |
2024-01-23 |
Empirico Inc. |
GalNAc compositions for improving siRNA bioavailability
|
|
WO2023198873A1
(en)
*
|
2022-04-14 |
2023-10-19 |
Immunic Ag |
Deuterated rorgamma/rorgammat inverse agonists
|
|
US20230382889A1
(en)
|
2022-04-28 |
2023-11-30 |
Volastra Therapeutics, Inc. |
Compounds for inhibiting kif18a
|
|
WO2023215367A1
(en)
|
2022-05-04 |
2023-11-09 |
Cytokinetics, Inc. |
Bicyclic piperazinones and therapeutic uses thereof
|
|
WO2023220741A1
(en)
|
2022-05-13 |
2023-11-16 |
Dice Molecules Sv, Inc. |
Alpha 4 beta 7 integrin modulators and uses thereof
|
|
WO2023225001A1
(en)
|
2022-05-16 |
2023-11-23 |
Vir Biotechnology, Inc. |
Naphthyridine based enpp1 modulators and uses thereof
|
|
US11939335B2
(en)
|
2022-05-17 |
2024-03-26 |
858 Therapeutics, Inc. |
Substituted imidazo[1,2-a]quinazolines and imidazo [1,2-a]pyrido[4,3-e]pyrimidines as inhibitors of PARG
|
|
WO2023225664A1
(en)
|
2022-05-19 |
2023-11-23 |
Dice Alpha, Inc. |
Lactam substituted imidazopyridazine il-17a modulators and uses thereof
|
|
WO2023230190A1
(en)
|
2022-05-25 |
2023-11-30 |
Quanta Therapeutics, Inc. |
Pyrimidine based modulators and uses thereof
|
|
WO2023235880A1
(en)
|
2022-06-02 |
2023-12-07 |
Aeovian Pharmaceuticals, Inc. |
Cd38 modulators and uses thereof
|
|
TW202412816A
(zh)
|
2022-06-10 |
2024-04-01 |
美商弗沃德醫療公司 |
ＴＮＦ—α活性調節劑
|
|
WO2023245137A1
(en)
|
2022-06-16 |
2023-12-21 |
Cytokinetics, Incorporated |
Slow skeletal troponin activators
|
|
TW202412784A
(zh)
|
2022-07-18 |
2024-04-01 |
美商依安彼克醫療有限公司 |
氮-喹唑啉化合物及使用方法
|
|
WO2024020380A1
(en)
|
2022-07-18 |
2024-01-25 |
Iambic Therapeutics, Inc. |
Quinazoline compounds and methods of use
|
|
WO2024020517A1
(en)
|
2022-07-22 |
2024-01-25 |
858 Therapeutics, Inc. |
3-(6-pyridin-3-yl)-2-[4-(4-methyl-4h-1,2,4-triazol-3-yl)piperidin-1-yl]benzonitrile derivatives and similar compounds as qpctl and qpct inhibitors for the treatment of cancer
|
|
WO2024030825A1
(en)
|
2022-08-01 |
2024-02-08 |
Neupharma, Inc |
Crystalline salts of crystalline salts of (3s,5r,8r,9s,10s,13r,14s,17r)-14-hydroxy-10,13-dimethyl-17-(2- oxo-2h-pyran-5-yl)hexadecahydro-1h-cyclopenta[a]phenanthren-3-yl piperazine-1-carboxylate
|
|
WO2024040190A1
(en)
|
2022-08-18 |
2024-02-22 |
Cytokinetics, Incorporated |
Indane and coumaran derivatives as fast skeletal muscle myosin inhibitors
|
|
WO2024064701A2
(en)
|
2022-09-20 |
2024-03-28 |
Biointervene, Inc. |
Adenosine analogs for the treatment of disease
|
|
WO2024073426A1
(en)
|
2022-09-26 |
2024-04-04 |
Edgewise Therapeutics, Inc. |
1,4-dihydroquinazolinone compounds and uses thereof
|
|
WO2024073371A1
(en)
|
2022-09-26 |
2024-04-04 |
Alterome Therapeutics, Inc. |
Akt1 modulators
|
|
WO2024105159A1
(en)
|
2022-11-16 |
2024-05-23 |
University Of Zurich |
Ligands of the m6a-rna readers
|
|
WO2024137981A1
(en)
|
2022-12-22 |
2024-06-27 |
Cytokinetics, Incorporated |
Nampt modulators
|